INPPL1 and Alzheimer disease: Recent network-based approach has unraveled that SHIP2 is also linked to AD and cognitive decline: upregulation of INPPL1 transcript in the brain significantly correlates with cognitive decline in human AD patients (Mostafavi et al., 2018).